24 March 2022 : Clinical Research
Efficacy of PD-1 Inhibitor Combined with Bevacizumab in Treatment of Advanced Endometrial Cancer Patients with Mismatch Repair Deficiency (dMMR)/High-Level Microsatellite Instability (MSI-H)
Ying Liao1BCE, Changhua Zhu
DOI: 10.12659/MSM.934493
Med Sci Monit 2022; 28:e934493

Figure 2 Tissue samples were tested by capillary electrophoresis to confirmation MSI. The figure was edited using Microsoft PowerPoint 2010 (Microsoft, Redmond, WA, USA) from a screen shot from the Applied Biosystems (ABI 3500 DX) in Shanghai Tech Laboratory Co., Ltd. (Shanghai, China).